TLPH - יחס מחיר לרווח לקצב צמיחה Talphera Corporation
Talphera, Inc. (TLPH) develops non-invasive pain management methods, ensuring a steady cash flow driven by inelastic demand from hospitals. The PEG ratio on GURU.Markets provides market valuation data, where 0.00 captures the current state of the parameter. The company's sublingual drugs accelerate patient discharge by replacing IV drips. Current US sales establish a foundation while the market currently prices in restructuring costs.
פילוחי מדדים ואנליטיקה של חברת Talphera, Inc. (TLPH)
Sales of sublingual pain management systems in the US generate a cash flow reflected in the PEG ratio. This metric compares the market value of earnings to the business expansion rate. The calculation is based on dividing the current P/E multiple by the annual earnings growth percentage. A value below one indicates that the asset is undervalued relative to its potential. For Talphera, Inc. (TLPH), this signals an opportunity for accelerated capital growth.
